✦ LIBER ✦

PNP10: COST-EFFECTIVENESS OF ATOMOXETINE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS

✍ Scribed by M Iskedjian; B Maturi; JH Walker; TR Einarson; S Khattak; G Carter

Book ID: 119594928
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 61 KB
Volume: 6
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)64038-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atomoxetine Treatment in Children and Ad

Atomoxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder

✍ Newcorn, Jeffrey H; Spencer, Thomas J; Biederman, Joseph; Milton, Denái R; Miche 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Efficacy and safety of atomoxetine in th

Efficacy and safety of atomoxetine in the treatment of attention deficit/hyperactivity disorder in children and adolescents

✍ W.J. Brown; J. Biederman; T. Spencer; J. Heiligenstein; J. Wernicke; A.J. Allen; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Treatment of Attention Deficit Hyperacti

Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

✍ Dr Mark L. Wolraich, Laura McGuinn, Melissa Doffing 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 109 KB

Cost Effectiveness of Guanfacine Extende

Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder

✍ Erder, M. Haim; Xie, Jipan; Signorovitch, James E.; Chen, Kristina S.; Hodgkins, 📂 Article 📅 2012 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 208 KB

Reading Outcomes of Children and Adolesc

Reading Outcomes of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia Following Atomoxetine Treatment

✍ Shaywitz, Bennett A.; Williams, David W.; Fox, Bethany K.; Wietecha, Linda A. 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 154 KB

PMH37 THE COST-EFFECTIVENESS OF GUANFACI

PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS

✍ Erder, M.; Chen, K.; Wu, E.Q.; Hodgkins, P.; Sikirica, V. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB